Therapy Of Metastatic Transitional Cell Carcinoma Of The Bladder With The Anti-Vascular Endothelial Cell Growth Factor Receptor (Flk1/Kdr) Monoclonal Antibody Dc101 And Paclitaxel.
CLINICAL CANCER RESEARCH（1999）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要